Company Profile

Oncogen Pharma is a research based pharmaceutical company with a global outlook to cancer treatment. Based in Malaysia, it is one of the fastest growing Pharmaceutical company in the country with the largest portfolio of Oncology products under development. Oncogen Pharma has established the most advanced R&D facilities for developing Oncology APIs and formulations for regulated markets. The diversified and qualified technical team of top professionals from different parts of the world have deep experience & exposure of the development of strategic products for global markets. 
Our global R&D center  for development of high potent APIs & Formulations is located in Shah Alam, Malaysia & is fully operational, It is spread across 40,000 square feet area & has full capability of developing several products at a time through vertical integration.


Oncogen’s Formulation plant is planned to be set-up on over a 4 acres of land in Enstek Park, Malaysia & is designed  by international experts  following stringent regulatory requirements by authorities across the globe including USFDA, PIC/S and WHO. This containment by Design (CbD) facility will have capabilities to develop Solid oral as well as Injectable products for regulated & key emerging markets. It can handle multiple potent products at a time which belong to OEB 4 and 5 categories in full containment fashion addressing needs of safety of product, person & environment. This facility would be the first QbD based designed  high containment facility with latest technology and advanced machineries sourced from top-rated manufacturers from across the world.. Such a facility with global accreditations would be perfectly suited for small scale operations for catering needs of clinical batch manufacturing as well as big manufacturing lots including commercial supply for various markets. 
Oncogen’s API manufacturing plant would also be a multiproduct commercial manufacturing facility built on separate piece of land near formulation manufacturing facility at Enstek Park, Malaysia & it would conduct commercial cGMP manufacturing of APIs for both clinical trial supplies and commercial products for global markets including USA. Moreover, Oncogen will be uniquely suited to provide the full spectrum of cGMP synthesis and chemical manufacturing services, from production of early stage clinical (grams) trial materials to product launch (kilograms) and successful commercialization. 


Our approach


Oncogen strives to develop new products, processes & markets. We work towards this by addressing unmet patient needs, ensuring that our medicines are readily available to the right patients at the right time, and by working with all partners to help ensure success along each step of the way; ultimately helping people get back to their daily lives by providing simple solutions for complex health issues.

We don’t just strive to create solutions that fit into pills or prescription bottles.
We strive to create solutions that fit into real life.

 

Vision & Mission


Our mission and vision statements are commitments we make to each other, our customers, and are paramount to anything we create in Oncogen. They are our guiding principles and provide us with alignment and clarity on what makes us unique in the field.


OUR VISION - To be most admired, scientifically driven & progressive pharmaceutical company of global footprints in the oncology treatment. 
OUR MISSION - “We endeavor to deliver affordable, quality medicines to cancer patients across the globe through our commitment to science, technology and passion for improving patients’ lives”
 

About the group


Oncogen Pharma (Malaysia) Sdn. Bhd. is a wholly-owned subsidiary company of Scitech Limited, a UAE based group having a vast successful experience of venturing into strategic healthcare businesses and development of world class healthcare facilities around the globe including a USFDA approved Pharmaceutical plant in India.